Document is current
Any future updates will be listed below
-
Authors
Binte Mohd Ikhsan, Siti Nurnadhirah https://orcid.org/0000-0002-2337-7260
Holt, Rosemary https://orcid.org/0000-0002-3650-0977
Man, Joyce https://orcid.org/0000-0001-8968-4223
Parsons, Tracey https://orcid.org/0009-0000-4122-4009
Schalbroeck, Rik https://orcid.org/0000-0002-9855-5797
Ruigrok, Amber https://orcid.org/0000-0001-7711-8056
Baranger, Aurélie
Allison, Carrie https://orcid.org/0000-0003-2272-2090
Doherty, Mary https://orcid.org/0000-0002-6995-3745
Van den Bosch, Katrien
Terčon, Jerneja https://orcid.org/0000-0001-7264-9464
Violland, Pierre https://orcid.org/0000-0003-2346-8039
Ghosh, Anjuli https://orcid.org/0009-0006-9138-0177
Cusack, James
Baron-Cohen, Simon https://orcid.org/0000-0001-9217-2544
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (777394)
Autism Centre of Excellence
- License Information
-
More Information
Article History
Received: 1 December 2024
Accepted: 2 May 2025
First Online: 14 June 2025
Declarations
:
: This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. All participants gave written informed consent in the ACCESS-EU study, which was approved by the Cambridge Psychology Research Ethics Committee (reference number PRE.2019.088). As this research involved an online survey, it adhered to ethical standards for informed consent, participant confidentiality, and data protection. All participants were provided with a clear informed consent form and assured that their participation was voluntary, anonymous, and confidential.
: Not applicable.
: Simon Baron-Cohen is the previous Editor-in-Chief of Molecular Autism.
